SCHEMBL9540029

SCHEMBL9540029

COc1ccc(CN2C(=O)NC(CCCO[Si](C)(C)C(C)(C)C)(C3CC3)c3cc(Cl)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 6/20 0.41
SCN9A Q15858 3/20 0.38
OPRL1 P41146 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
KDM4E B2RXH2 1/20 0.34
HTT P42858 1/20 0.34
CHRM5 P08912 2/20 0.33
CASP3 P42574 1/20 0.33
CASP7 P55210 1/20 0.33
POLB P06746 1/20 0.33
EDNRB P24530 2/20 0.33
EDNRA P25101 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9540149 0.84 PTGDR2 (0.48) PTGDR2SCN9AOPRL1MEN1ALDH1A1
SCHEMBL9540160 0.83 PTGDR2 (0.46) PTGDR2SCN9AOPRL1MEN1ALDH1A1
SCHEMBL9539009 0.83 PTGDR2 (0.46) PTGDR2SCN9AOPRL1MEN1ALDH1A1
SCHEMBL9539116 0.83 PTGDR2 (0.41) PTGDR2SCN9AOPRL1MAPTCHRM5
SCHEMBL9542778 0.82 PTGDR2 (0.47) PTGDR2SCN9AOPRL1MEN1ALDH1A1
SCHEMBL9540119 0.81 PTGDR2 (0.41) PTGDR2SCN9AOPRL1MEN1ALDH1A1
SCHEMBL9540078 0.81 PTGDR2 (0.49) PTGDR2SCN9AMEN1ALDH1A1MAPT
SCHEMBL9539952 0.80 PTGDR2 (0.43) PTGDR2SCN9AOPRL1MEN1ALDH1A1
SCHEMBL9540101 0.80 PTGDR2 (0.46) PTGDR2SCN9AOPRL1MEN1ALDH1A1
SCHEMBL9540137 0.78 PTGDR2 (0.47) PTGDR2SCN9AOPRL1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed